BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, announced today that it intends to conduct meetings with certain analysts and institutional investors next week.
